The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
Open Access
- 1 December 2021
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 13 (4), 468-472
- https://doi.org/10.4274/jcrpe.galenos.2020.2020.0160
Abstract
The current Coronavirus disease-2019 (COVID-19) pandemic has forced health care teams to look for alternative approaches to manage a great number of children with diabetes, not only in rural but also in urban locations. The aim was to assess the provision of information about follow-up of new-onset pediatric type 1 diabetes (T1D) patients, and to investigate the integration of telemedicine into routine clinical care in the long term. The changes in coefficient of variation (CV), standard deviation and percentages of time in range (TIR), time below range (TBR) and time above range were evaluated in eight children with new-onset T1D, diagnosed during the COVID-19 pandemic. The study period was two-months of follow-up using a telemedicine system. Median follow-up time was 51 (24-66) days. Two of the patients were using low glucose suspend system and six were on multiple daily injection therapy. Target TIR values were achieved in seven patients in the last televisit and, in line with recent guidelines, a TBR <70 mg/dL (<3.9 mmol/L) (level 1 hypoglycemia) of <4% and a TBR <54 mg/dL (<3.0 mmol/L) (level 2 hypoglycemia) of <1% were achieved in all patients. Seven patients achieved a CV of <36% at their last televisit. Telemedicine as an alternative follow-up tool during unusual circumstances such pandemics, even in countries where it is not routinely used, could be beneficial to achieve optimum glycemic control in patients with new-onset T1D.Keywords
This publication has 18 references indexed in Scilit:
- ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologiesPediatric Diabetes, 2018
- The 36% coefficient of variation for glucose proposed for separating stable and labile diabetes is clinically relevant: A continuous glucose monitoring-based study in a large population of type 1 diabetes patientsDiabetes & Metabolism, 2018
- Continuous glucose monitoring: A review of the technology and clinical useDiabetes Research and Clinical Practice, 2017
- Impact of health workforce availability on health care seeking behavior of patients with diabetes mellitus in ChinaInternational Journal for Equity in Health, 2017
- Telemedicine for the Management of Glycemic Control and Clinical Outcomes of Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled StudiesFrontiers in Pharmacology, 2017
- Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!Diabetes Care, 2015
- Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers!Diabetes Care, 2015
- Telemedicine Diabetes Consultations are Cost-Effective, and Effects on Essential Diabetes Treatment Parameters are Similar to Conventional Treatment: 7-Year Results from the Svendborg Telemedicine Diabetes ProjectJournal of Diabetes Science and Technology, 2013
- Diabetes care: provider disparities in the US Appalachian regionRural and Remote Health, 2010
- School-Centered Telemedicine for Children with Type 1 Diabetes MellitusThe Journal of Pediatrics, 2009